Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weiller

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDIP Amorim, Y Lecrubier, E Weiller, et al.
Journal of Affective Disorders|May 29, 2013
DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial dataR S McIntyre, M Tohen, M Berk, et al.
Current Medical Research and Opinion|January 14, 2010
Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetineJ P Boulenger, A Hermes, A K T Huusom, et al.
Psychopathology|January 1, 1995
Recurrent brief depression: clinical and epidemiological issuesJ P Lepine, A Pelissolo, E Weiller, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1989
[The initial acute renal failure and late manifestation of extrarenal symptoms in Wegener's disease]J Schirmeister, F E Weiller, R Walter, et al.
Therapie|March 1, 1991
[Personality of healthy volunteers. Normality and paradox]P Danjou, D Warot, E Weiller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1996
Social phobia in general health care: an unrecognised undertreated disabling disorderE Weiller, J C Bisserbe, P Boyer, et al.
International Clinical Psychopharmacology|June 1, 1996
Social phobia in primary care: level of recognition and drug useJ C Bisserbe, E Weiller, P Boyer, et al.
Therapie|January 1, 1991
[Comparative effects of ginkgo biloba extracts on psychomotor performances and memory in healthy subjects]D Warot, L Lacomblez, P Danjou, et al.
Human Psychopharmacology|December 1, 2004
Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetineP Vandel, D Sechter, E Weiller, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2009
DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDIP Amorim, Y Lecrubier, E Weiller, et al.
Journal of Affective Disorders|May 29, 2013
DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial dataR S McIntyre, M Tohen, M Berk, et al.
Current Medical Research and Opinion|January 14, 2010
Baseline anxiety effect on outcome of SSRI treatment in patients with severe depression: escitalopram vs paroxetineJ P Boulenger, A Hermes, A K T Huusom, et al.
Psychopathology|January 1, 1995
Recurrent brief depression: clinical and epidemiological issuesJ P Lepine, A Pelissolo, E Weiller, et al.
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1989
[The initial acute renal failure and late manifestation of extrarenal symptoms in Wegener's disease]J Schirmeister, F E Weiller, R Walter, et al.
Therapie|March 1, 1991
[Personality of healthy volunteers. Normality and paradox]P Danjou, D Warot, E Weiller, et al.
The British Journal of Psychiatry : the Journal of Mental Science|February 1, 1996
Social phobia in general health care: an unrecognised undertreated disabling disorderE Weiller, J C Bisserbe, P Boyer, et al.
International Clinical Psychopharmacology|June 1, 1996
Social phobia in primary care: level of recognition and drug useJ C Bisserbe, E Weiller, P Boyer, et al.
Therapie|January 1, 1991
[Comparative effects of ginkgo biloba extracts on psychomotor performances and memory in healthy subjects]D Warot, L Lacomblez, P Danjou, et al.
Human Psychopharmacology|December 1, 2004
Post-treatment emergent adverse events in depressed patients following treatment with milnacipran and paroxetineP Vandel, D Sechter, E Weiller, et al.
Pageof 3